Learn / Metrics / Price-to-Sales (P/S) Ratio
Valuation

Price-to-Sales (P/S) Ratio

Quick Answer

The P/S Ratio divides a company's market capitalization by its annual revenue, measuring how many dollars investors pay for each dollar of sales. Unlike the P/E Ratio, it remains useful when a company has no earnings, making it a standard valuation tool for early-stage, high-growth, and cyclically distressed businesses.

What is the Price-to-Sales (P/S) Ratio?

Revenue exists before profits. A company can generate billions in sales while reporting a net loss, which is common in high-growth technology, biotechnology, and early-stage businesses across many sectors. The P/E Ratio fails in these situations: divide by zero or negative earnings and you get nothing useful. The P/S Ratio sidesteps this problem entirely. It anchors valuation to the top line, which is typically positive even when earnings are not.

Consider two companies in the same software sector. Company A has a market cap of 5 billion dollars and annual revenue of 500 million dollars, producing a P/S of 10. Company B has a market cap of 1 billion dollars and revenue of 200 million dollars, producing a P/S of 5. Company B appears cheaper by this measure. Whether that cheapness is warranted depends on growth rates, margins, and competitive position, but the P/S Ratio provides a comparable starting point when earnings data is absent or unreliable.

The ratio also captures market expectations about future profitability. A P/S of 20 in software implies the market believes the company will convert a substantial fraction of those revenues into profits at scale. When that belief proves wrong, stocks with elevated P/S ratios tend to fall sharply. The 2022 growth stock correction was in large part a P/S re-rating: companies that traded at 30 to 50 times revenue in 2021 compressed to 5 to 10 times as interest rates rose and growth expectations moderated. This re-rating cycle illustrated both the usefulness and the danger of relying heavily on P/S for high-multiple names.

Formula

P/S = Market Capitalization / Trailing Twelve-Month Revenue
Market Cap = Current Share Price times Shares Outstanding; Revenue = net sales from the trailing four reported quarters

Market capitalization represents the total market value of the equity. Revenue is the top-line figure before any expenses are deducted. SledgeKey uses TTM (trailing twelve-month) revenue derived from point-in-time quarterly filings. As of any historical screening date, the revenue figure reflects only the filings that had been publicly released at that time. No future quarters are incorporated, ensuring that backtests reflect the information actually available to investors on each historical date.

The P/S Ratio can also be computed per share by dividing the stock price by revenue per share. This produces the identical ratio. One refinement worth knowing is EV/Sales, which substitutes enterprise value (market cap plus net debt) for market cap. This adjustment accounts for different capital structures: a company with 2 billion dollars in debt and a 3 billion dollar market cap has a very different leverage profile than a debt-free competitor with the same market cap. EV/Sales corrects for this, making cross-company comparisons cleaner in capital-intensive industries.

How to Interpret the Price-to-Sales (P/S) Ratio

The core interpretive challenge with P/S is that it is a margin-agnostic ratio. A grocery chain with 1 percent net margins will justifiably trade at a P/S of 0.2. A high-margin software company with 30 percent net margins deserves a P/S of 10 or higher. Neither is automatically cheap or expensive; both reflect rational pricing given their respective margin structures. Applying a single absolute P/S threshold across all sectors produces misleading screens.

Range Typical Interpretation Context
Below 1.0 Deep value or low-margin business Typical for retail, food distribution, and commodity businesses with thin operating margins
1.0 to 3.0 Moderate valuation Common for industrials, financial services, and healthcare services
3.0 to 8.0 Growth or quality premium Consumer brands, healthcare technology, specialty software with proven margins
Above 10.0 High-growth or high-margin premium SaaS platforms and high-conviction growth names; requires sustained growth or margin expansion to justify

A useful sanity check is the implied margin calculation. Divide net income by revenue to get the current net margin, then ask whether the P/S ratio is consistent with that margin at a reasonable terminal P/E. A company earning 5 percent net margins trading at a P/S of 15 implies a P/E of 300, which is almost never justifiable. This framework reveals stretched valuations that the P/S ratio alone does not flag.

The most common mistake is treating a low P/S as a sign of cheapness without examining why. A grocery chain at 0.2x P/S is not cheap in any meaningful investment sense: it just has thin margins that the market correctly prices as low-multiple. P/S must always be paired with margin analysis and growth rate assessment before conclusions can be drawn.

Why the Price-to-Sales (P/S) Ratio Matters for Investors

The P/S Ratio fills a genuine gap in the valuation toolkit. Growth investors who screen out unprofitable companies miss large portions of the market, including many businesses that later become dominant in their categories. Amazon traded at double-digit P/S ratios for most of its first decade as a public company before its margins expanded dramatically. A rigid requirement for positive earnings would have eliminated it throughout that entire period.

For cyclical industries, P/S is valuable precisely because earnings can temporarily go negative at the trough of a business cycle. Steel, energy, and semiconductor companies all experience periods where earnings collapse while revenue merely declines. P/S allows comparisons across the cycle without the distortions caused by near-zero or negative EPS. An energy company at 0.4x P/S during an oil price collapse may be genuinely cheap if the business can survive the trough, and P/S is the only ratio that captures this without producing meaningless negative multiples.

Using the Price-to-Sales (P/S) Ratio in Stock Screening

James O'Shaughnessy, in "What Works on Wall Street," identified P/S as one of the single most effective value factors. His research across decades of market data found that stocks in the lowest P/S quintile generated significantly higher subsequent returns than the market, with excess returns of 3 to 5 percent annually in some study periods. The underlying logic: low P/S often captures businesses priced for persistent mediocrity that later improve their margins or attract acquisition interest.

In SledgeKey, P/S screens work well in combination with revenue growth filters. A screen for P/S below 2.0 paired with revenue growth above 10 percent targets companies growing faster than their valuation implies, capturing businesses that have not yet converted revenue growth into earnings but show the trajectory to do so. This Growth at a Reasonable Price approach applied to the top line avoids both the overpayment risk of high-P/S growth and the value trap risk of low-P/S stagnation.

Sector-relative P/S screening produces more consistent results than market-wide absolute thresholds. Requiring P/S below the 25th percentile within each sector eliminates structural sector bias while maintaining discipline on valuation. A financial services company at P/S 4 and a software company at P/S 4 sit in very different positions relative to their peer groups, and a sector-aware screen captures that distinction.

Backtesting with the Price-to-Sales (P/S) Ratio

O'Shaughnessy's research remains the most comprehensive historical study of P/S as a standalone factor. In backtests covering 1951 to 1994, low P/S portfolios (bottom quintile) compounded at roughly 18 percent annually versus approximately 12 percent for the broader market. Later extensions of the study through 2010 showed continued outperformance, though with significant variability across market regimes and notable underperformance during the late 1990s technology bubble.

The late 1990s experience is instructive. P/S-based value strategies suffered badly from 1998 to 2000 as technology stocks with minimal revenue traded at enormous premiums. Low-P/S portfolios at that time were concentrated in sectors that lagged the technology rally, producing painful tracking error before the eventual reversion. This is a recurring tension in P/S investing: the low-P/S universe at market peaks often contains businesses that are inexpensive for structural reasons, while elevated P/S names can sustain high ratios for extended periods before correcting.

Point-in-time data is particularly important for P/S backtesting. Revenue figures are frequently revised in subsequent filings, sometimes materially. Studies using the most recently available revenue data will produce results different from those using the numbers originally reported. SledgeKey uses the revenue from the filing available as of the screening date, ensuring historical backtests reflect what investors actually knew rather than revised history.

Screen stocks using the P/S Ratio

Set P/S Ratio filters and combine with revenue growth, gross margin, and other metrics across 6,000+ NYSE and NASDAQ securities, then backtest your strategy against historical data, free.

Start Screening
Written by The SledgeKey Team ยท Last updated April 10, 2026